Wave Life Sciences, Inc. WVE
3.66 USD +0.07 (+2.09%)
Nov 4, 2026, 10:09 AM EST
3.65 Day range 3.78
3.04 52-week range 21.73
- YTD
- -78.50%
- 1 year
- -54.37%
Held by funds
95 US ETFs and mutual funds hold WVE · largest positions
Ownership
Held by insiders 15.50%
Held by institutions 85.60%
Float held by institutions 101.31%
Institutions 330
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kennedy Capital Management, LLC | 0.00% | 429,121 | 2.21M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 2.09% | 4,111,308 | 21.21M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.83% | 3,598,451 | 18.57M | Jun 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.16% | 2,287,103 | 11.80M | Mar 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 1.07% | 2,107,233 | 10.87M | Mar 30, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 0.84% | 1,659,857 | 8.56M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.82% | 1,610,961 | 8.31M | Mar 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOLNO PAUL B. M.D. | Chief Executive Officer | Sale | Feb 8, 2026 | 275,520 |
| CORRIGAN MARK | Director | Sale | Dec 7, 2025 | 28,815 |
| FRANCIS CHRISTOPHER JOHN | Officer | Conversion of Exercise of derivative security | Feb 25, 2026 | 61,867 |
| GSK PLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 10, 2025 | 0 |
| MORAN KYLE | Chief Financial Officer | Sale | Feb 8, 2026 | 134,385 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 29, 2026 | 0 |